Capillary electrophoresis encompasses a rapidly evolving range of consumables, software, and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. Capillary electrophoresis also offers prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy and is broadly used for nucleic acid analysis and protein analysis applications.
Our healthcare experts have found the capillary electrophoresis market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 5.66% during the forecast period 2021-2031.
Factors fueling the growth of the market include strategic initiatives by key market players and increasing adoption of sequencing in various research fields increase in adoption of personalized medicine; despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth. Lack of infrastructure and expertise high capital requirement hampering the expansion of global reach uncertain reimbursement scenario further, some of the opportunities, such as government and private support for capillary electrophoresis on large-scale novel diagnostic applications, provide growth to the market.
The exponential rise in the prevalence of infectious diseases and various types of cancer on the global level has created a buzz among companies to invest in advanced technologies such as molecular diagnostics.
Continue reading about regional analysis: https://www.giiresearch.com/report/bis1066955-capillary-electrophoresis-market-global-regional.html
Contact: [email protected]
Global Information, Inc. [JASDAQ 4171] https://www.giiresearch.com/ Toll Free (US): +1-866-353-3335 Outside US: +1-860-674-8796 Europe (Belgium): +32-2-535-7543 Email: [email protected]